<?xml version="1.0" encoding="UTF-8"?>
<p>Therapeutic approaches to be employed in the treatment of lung cancer are dependent on the stage of cancer. Currently lung cancer is treated by chemotherapy, immunotherapy, targeted therapy, and radiotherapy. Although immunotherapy has made tremendous progress in the treatment and management of lung cancer, chemotherapy is the current standard treatment to be employed in the first and second line in the management of small-cell lung cancer (SCLC) [
 <xref rid="B79-molecules-25-04435" ref-type="bibr">79</xref>]. Pre-clinical trials of 6-Shogaol, a bioactive compound extracted from ginger, have shown effectiveness in the treatment of non-small-cell lung cancer (NSCLC). In an experimental model involving a nude mouse, 6-Shogaol inhibited the growth of lung cancer cells. The growth inhibition of NSCLC was significantly associated with the decreased proliferation and increased apoptosis induction [
 <xref rid="B27-molecules-25-04435" ref-type="bibr">27</xref>].
</p>
